Caffeic Acid Phenethyl Ester Abrogates Bone Resorption in a Murine Calvarial Model of Polyethylene Particle-Induced Osteolysis

Abstract

Particle-induced bone loss by osteoclasts is a common cause of aseptic loosening around implants. This study investigates whether caffeic acid phenethyl ester (CAPE), a potent and specific inhibitor of nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1 and nuclear factor kappa B, at a low dose reduces bone resorption in a murine calvarial model of polyethylene (PE) particle-induced osteolysis. The effects of particles and CAPE treatment on gastrointestinal tract (GIT) histopathology were also evaluated. Mice were scanned using in vivo animal micro-computed tomography (μCT) as a baseline measurement. PE particles (2.82 × 109 particles/mL) were implanted over the calvariae on day 0. CAPE was administered subcutaneously (1 mg/kg/day) at days 0, 4, 7 and 10. Mice were killed at day 14 and serum was analysed for Type-1 carboxyterminal collagen crosslinks (CTX)-1 and osteoclast-associated receptor (OSCAR) levels. Ex vivo μCT scans were conducted to assess bone volume (BV) change and percentage area of calvarial surface resorbed. Calvarial and GIT tissue was processed for histopathology. By day 14, PE particles significantly induced calvarial bone loss compared with control animals as evidenced by resorption areas adjacent to the implanted PE in three-dimensional μCT images, an increase in percentage of resorbed area (p = 0.0022), reduction in BV (p = 0.0012) and increased Tartrate-resistant acid phosphatase positive cells. Serum CTX-1 (p = 0.0495) and OSCAR levels (p = 0.0006) significantly increased in the PE implant group. CAPE significantly inhibited PE particle-induced calvarial osteolysis, as evidenced by a significant reduction in surface bone resorption (p = 0.0012) and volumetric change (p = 0.0154) compared with PE only, but had no effect on systemic CTX-1. Neither particles nor CAPE had an effect on GIT histopathology.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. 1.

    Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM (2001) The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg Br 83:902–911

    Article  CAS  PubMed  Google Scholar 

  2. 2.

    Crotti TN, Smith MD, Findlay DM, Zreiqat H, Ahern MJ, Weedon H, Hatzinikolous G, Capone M, Holding C, Haynes DR (2004) Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Biomaterials 25:565–573

    Article  CAS  PubMed  Google Scholar 

  3. 3.

    Holding CA, Findlay DM, Stamenkov R, Neale SD, Lucas H, Dharmapatni AS, Callary SA, Shrestha KR, Atkins GJ, Howie DW, Haynes DR (2006) The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants. Biomaterials 27:5212–5219

    Article  CAS  PubMed  Google Scholar 

  4. 4.

    Tuan RS, Lee FY, Konttinen YT, Wilkinson JM, Smith RL (2008) What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles? J Am Acad Orthop Surg 16(Suppl 1):S42–S48

    PubMed Central  PubMed  Google Scholar 

  5. 5.

    Mikuls TR (2003) Co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 17:729–752

    Article  PubMed  Google Scholar 

  6. 6.

    Crotti TN, Sharma SM, Fleming JD, Flannery MR, Ostrowski MC, Goldring SR, McHugh KP (2008) PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter. J Cell Physiol 215:636–644

    Article  CAS  PubMed  Google Scholar 

  7. 7.

    Crotti TN, Flannery M, Walsh NC, Fleming JD, Goldring SR, McHugh KP (2006) NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation. Gene 372:92–102

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. 8.

    Clohisy JC, Roy BC, Biondo C, Frazier E, Willis D, Teitelbaum SL, Abu-Amer Y (2003) Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis. J Immunol 171:5547–5553

    Article  CAS  PubMed  Google Scholar 

  9. 9.

    Yip KH, Zheng MH, Feng HT, Steer JH, Joyce DA, Xu J (2004) Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity. J Bone Miner Res 19:1905–1916

    Article  CAS  PubMed  Google Scholar 

  10. 10.

    Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, Puzas JE, O’Keefe RJ (2000) Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 18(3):472–480

    Article  CAS  PubMed  Google Scholar 

  11. 11.

    Gordon AH, O’Keefe RJ, Schwarz EM, Rosier RN, Puzas JE (2005) Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone. Cancer Res 65:3209–3217

    CAS  PubMed  Google Scholar 

  12. 12.

    Li Y, Zhang C, Zhou X, Wang H, Mao Y, Wang X (2013) Parthenolide inhibits polyethylene particle-induced mouse calvarial osteolysis in vivo. J Surg Res 12:176–181

    Google Scholar 

  13. 13.

    Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758–763

    Article  CAS  PubMed  Google Scholar 

  14. 14.

    Kim Y, Sato K, Asagiri M, Morita I, Soma K, Takayanagi H (2005) Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J Biol Chem 280:32905–32913

    Article  CAS  PubMed  Google Scholar 

  15. 15.

    Ishikawa S, Arase N, Suenaga T, Saita Y, Noda M, Kuriyama T, Arase H, Saito T (2004) Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR). Int Immunol 16(7):1019–1025

    Article  CAS  PubMed  Google Scholar 

  16. 16.

    Alias E, Dharmapatni ASSK, Holding AC, Atkins GJ, Findlay DM, Howie DW, Crotti TN, Haynes DR (2012) Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro. Acta Biomater 8(8):3104–3112

    Article  CAS  PubMed  Google Scholar 

  17. 17.

    Zawawi MSF, Dharmapatni AA, Cantley MD, McHugh KP, Haynes DR, Crotti TN (2012) Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation. Biochem Biophys Res Commun 427(2):404–409

    Article  CAS  PubMed  Google Scholar 

  18. 18.

    Crotti TN, Dharmapatni AA, Alias E, Zannettino AC, Smith MD, Haynes DR (2012) The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. Arthr Res Ther 14:R245

    Article  CAS  Google Scholar 

  19. 19.

    Herman S, Muller RB, Kronke G, Zwerina J, Redlich K, Hueber AJ, Gelse H, Neumann E, Muller-Ladner U, Schett G (2008) Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. Arthr Rheum 58:3041–3050

    Article  CAS  Google Scholar 

  20. 20.

    Zhao S, Guo YY, Ding N, Yang LL, Zhang N (2011) Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis. Chin Med J (Engl) 124:3058–3060

    Google Scholar 

  21. 21.

    Ndongo-Thiam N, de Sallmard G, Kastrup J, Miossec P (2014) Levels of soluble osteoclast-associated receptor (sOSCAR) in rheumatoid arthritis: link to disease severity and cardiovascular risk. Ann Rheum Dis 73(6):1276–1277

    Article  PubMed  Google Scholar 

  22. 22.

    Natarajan K, Singh S, Burke TRJR, Grunberger D, Aggarwal BB (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 93(17):9090–9095

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. 23.

    Ang ES, Pavlos NJ, Chai LY, Qi M, Cheng TS, Steer JH, Joyce DA, Zheng MH, Xu J (2009) Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity. J Cell Physiol 221:642–649

    Article  CAS  PubMed  Google Scholar 

  24. 24.

    Marquez N, Sancho R, Macho A, Calzado MA, Fiebich BL, Munoz E (2004) Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors. J Pharmacol Exp Ther 308:993–1001

    Article  CAS  PubMed  Google Scholar 

  25. 25.

    Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T, Dannenberg AJ (1999) Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59:2347–2352

    CAS  PubMed  Google Scholar 

  26. 26.

    Fitzpatrick LR, Wang J, Le T (2001) Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J Pharmacol Exp Ther 299(3):915–920

    CAS  PubMed  Google Scholar 

  27. 27.

    Wedemeyer C, Xu J, Neuerburg C, Landgraeber S, Malyar NM, von Knoch F, Gosheger G, von Knoch M, Loer F, Saxler G (2007) Particle-induced osteolysis in three-dimensional micro-computed tomography. Calcif Tissue Int 81:394–402

    Article  CAS  PubMed  Google Scholar 

  28. 28.

    Zhou X, Zhang C, Wang X, An B, Zhang P, Zhu Z (2012) Berberine inhibits lipopolysaccharide- and polyethylene particle-induced mouse calvarial osteolysis in vivo. J Surg Res 173:e47–e52

    Article  CAS  PubMed  Google Scholar 

  29. 29.

    von Knoch M, Sprecher C, Barden B, Saxler G, Löer F, Wimmer M (2004) Size and shape of commercially available polyethylene particles for in vitro and in vivo-experiments. Z Orthop Ihre Grenzgeb 142(3):366–370

    Article  Google Scholar 

  30. 30.

    Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL (1999) Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 154:203–210

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. 31.

    Cantley MD, Bartold PM, Marino V, Reid RC, Fairlie DP, Wyszynski RN, Zilm PS, Haynes DR (2009) The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A2inhibitor on alveolar bone loss in anin vivomouse model of periodontitis. J Periodontal Res 44:317–322

    Article  CAS  PubMed  Google Scholar 

  32. 32.

    Perilli E, Le V, Ma B, Salmon P, Reynolds K, Fazzalari NL (2010) Detecting early bone changes using in vivo micro-CT in ovariectomized, zoledronic acid-treated, and sham-operated rats. Osteoporos Int 21:1371–1382

    Article  CAS  PubMed  Google Scholar 

  33. 33.

    Shen Z, Crotti TN, McHugh KP, Matsuzaki K, Gravallese EM, Bierbaum BE, Goldring SR (2006) The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Arthr Res Ther 8:R70

    Article  Google Scholar 

  34. 34.

    Burstone M (1958) Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J Natl Cancer Inst 21:523–539

    CAS  PubMed  Google Scholar 

  35. 35.

    Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T (1989) The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805–1813

    Article  CAS  PubMed  Google Scholar 

  36. 36.

    Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM (2003) Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 18(9):1095–1100

    Article  CAS  PubMed  Google Scholar 

  37. 37.

    Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM (2008) Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 62(1):33–41

    Article  CAS  PubMed  Google Scholar 

  38. 38.

    Kurtz SM, Ok M, Evans M, Edidin AA (1999) Advances in the processing, sterilization, and crosslinking of ultra-high molecular weight polyethylene for total joint arthroplasty. Biomaterials 20(18):1659–1688

    Article  CAS  PubMed  Google Scholar 

  39. 39.

    Landgraeber S, Jaeckel S, Loer F, Wedemeyer C, Hilken G, Canbay A, Totsch M, von Knoch M (2009) Pan-caspase inhibition suppresses polyethylene particle-induced osteolysis. Apoptosis Int J Program Cell Death 14:173–181

    Article  CAS  Google Scholar 

  40. 40.

    Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, von Knoch F, Hilken G, Brankamp J, Henschke F, von Knoch M, Loer F, Saxler G (2007) Polyethylene particle-induced bone resorption in substance P-deficient mice. Calcif Tissue Int 80(4):268–274

    Article  CAS  PubMed  Google Scholar 

  41. 41.

    Ha J, Choi HS, Lee Y, Lee ZH, Kim HH (2009) Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. Int Immunopharmacol 9:774–780

    Article  CAS  PubMed  Google Scholar 

  42. 42.

    Ang E, Pavlos NJ, Rea SL, Qi M, Chai T, Walsh JP, Ratajczak T, Zheng MH, Xu J (2009) Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades. J Cell Physiol 220:450–459

    Article  CAS  PubMed  Google Scholar 

  43. 43.

    Kim N, Takami M, Rho J, Josien R, Choi Y (2002) A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med 195:201–209

    PubMed Central  CAS  PubMed  Google Scholar 

  44. 44.

    Nemeth K, Schoppet M, Al-Fakhri N, Helas S, Jessberger R, Hofbauer LC, Goettsch C (2011) The role of osteoclast-associated receptor in osteoimmunology. J Immunol 186(1):13–18

    Article  CAS  PubMed  Google Scholar 

  45. 45.

    Orban Z, Mitsiades N, Burke TRJ, Tsokos M, Chrousos GP (2000) Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. NeuroImmunoModulation 7(2):99–105

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The work has been supported by a New Appointment Grant, Faculty of Health Sciences, The University of Adelaide. The Malaysian Government (USM) provided support for M. S. F. Z.

Conflict of interest

M. S. F. Zawawi, E. Perilli, R. L. Stansborough, V. Marino, M. D. Cantley, J. Xu, A. A. S. S .K. Dharmapatni, D. R. Haynes, R. J. Gibson and T. N. Crotti state that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This study was conducted in accordance with ethics approved by The University of Adelaide (M-2001-070) and SA Pathology (106/10) and complied with the National Health and Medical Research Council (Australia) Code of Practice for Animal Care in Research and Teaching (2014).

Author information

Affiliations

Authors

Corresponding author

Correspondence to T. N. Crotti.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zawawi, M.S.F., Perilli, E., Stansborough, R.L. et al. Caffeic Acid Phenethyl Ester Abrogates Bone Resorption in a Murine Calvarial Model of Polyethylene Particle-Induced Osteolysis. Calcif Tissue Int 96, 565–574 (2015). https://doi.org/10.1007/s00223-015-9982-8

Download citation

Keywords

  • Osteolysis
  • CAPE
  • NF kappa B inhibitor
  • Micro-CT
  • CTX-1
  • OSCAR